Near-infrared light-controllable bufalin delivery from a black phosphorus-hybrid supramolecular hydrogel for synergistic photothermal-chemo tumor therapy
- 5 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nano Research
- Vol. 14 (11), 3988-3998
- https://doi.org/10.1007/s12274-021-3325-z
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mussel-inspired sandwich-like nanofibers/hydrogel composite with super adhesive, sustained drug release and anti-infection capacityChemical Engineering Journal, 2020
- Conformational states of the pig kidney Na+/K+-ATPase differently affect bufadienolides and cardenolides: A directed structure-activity and structure-kinetics studyBiochemical Pharmacology, 2020
- Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004‐2015Cancer, 2019
- Tissue Response and Biodistribution of Injectable Cellulose Nanocrystal Composite HydrogelsACS Biomaterials Science & Engineering, 2019
- The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trialsGastric Cancer, 2018
- Assembly of Au Plasmonic Photothermal Agent and Iron Oxide Nanoparticles on Ultrathin Black Phosphorus for Targeted Photothermal and Photodynamic Cancer TherapyAdvanced Functional Materials, 2017
- A supramolecular hydrogelator of curcuminChemical Communications, 2014
- Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERKMolecular Biology Reports, 2011
- Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cellsJournal of Ethnopharmacology, 2010
- Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: Cardiotoxicity due to more than Na, K-ATPase blockingLife Sciences, 2002